OPRX stock news · OptimizeRx Corporation
Get alerts for OPRX
Follow OptimizeRx Corporation (OPRX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for OPRXFree on the App Store and Google Play, or on the web.
After better-than-expected earnings, analysts lowered their sales predictions for OptimizeRx.
NeutralOptimizeRx cut its 2026 sales forecast to $87 million–$93 million, even as Q3 sales and profit beat estimates. Wider margins help, but weaker sales expectations leave its outlook mixed.